Chiropractors in Fulton, NY Accepting Medicare

5 Chiropractors found. Showing 1 - 5

Kori L Birchenough, D.C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 53 S 3rd St, Fulton, NY 13069 Phone: 315-593-7555    Fax: 315-207-0023

Dr. Brett Riley Tallents, D.C. Chiropractor - Orthopedic Medicare: May Accept Medicare Assignments Practice Location: 53 S 3rd St, Fulton, NY 13069 Phone: 315-593-7555    Fax: 315-598-8352

Community Chiropractic, P.c. Chiropractor Medicare: Medicare Enrolled Practice Location: 16 Canalview Mall, Fulton, NY 13069 Phone: 315-592-4740    Fax: 315-592-7423

David L Stuber, DC Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 362 Park Ave, Fulton, NY 13069 Phone: 315-593-6336

Patrick J. Nicholson, D.C. Chiropractor Medicare: May Accept Medicare Assignments Practice Location: 16 Canalview Mall, Fulton, NY 13069 Phone: 315-592-4740

News Archive

Researchers identify CHK1 protein may serve as treatment target for neuroblastoma

After analyzing hundreds of proteins produced by the DNA of tumor cells, researchers have identified one protein that may be central to a new treatment for the often-fatal childhood cancer neuroblastoma. Oncologists hope to translate the finding into pediatric clinical trials of a drug that blocks the protein's activity.

iCo Therapeutics reports financial results for first quarter 2015

iCo Therapeutics, today reported financial results for the quarter ended March 31, 2015. Amounts, unless specified otherwise, are expressed in Canadian dollars and presented under International Financial Reporting Standards ("IFRS").

New health MOT-style programme likely to uncover more diabetes, kidney or heart patients

University of Leicester researchers have found that the NHS Health Check Programme is likely to find 440,000 people each year who have diabetes or chronic kidney disease or who are at high risk of cardiovascular disease or diabetes.

Delivery of standardized diabetes care could help achieve equitable health outcomes for all patients

Although kidney problems related to type 2 diabetes disproportionately affect blacks, when black and white individuals received comparable diabetes care within the context of a clinical trial, black race was not associated with faster development or progression of chronic kidney disease.

arGEN-X BV announces first closing of its Series A equity financing round

arGEN-X BV, a biopharmaceutical company focused on the discovery and development of human antibodies using its proprietary SIMPLE Antibody platform, today announced the successful first closing of its Series A equity financing round. The Company raised EUR 9.5million (~ USD 13.6 million) from a syndicate of leading life science investors. The financing round is one of the largest of its kind in the last 12 months.

Read more Medical News

› Verified 2 days ago